- Home
- TALO vs CNTA Comparison
TALO vs CNTA Comparison
Compare TALO & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALO
- CNTA
- Stock Information
- Founded
- TALO 2011
- CNTA 2020
- Country
- TALO United States
- CNTA United Kingdom
- Employees
- TALO N/A
- CNTA N/A
- Industry
- TALO Oil & Gas Production
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- TALO Energy
- CNTA Health Care
- Exchange
- TALO Nasdaq
- CNTA Nasdaq
- Market Cap
- TALO 1.5B
- CNTA 1.6B
- IPO Year
- TALO N/A
- CNTA 2021
- Fundamental
- Price
- TALO $8.05
- CNTA $13.51
- Analyst Decision
- TALO Buy
- CNTA Strong Buy
- Analyst Count
- TALO 8
- CNTA 11
- Target Price
- TALO $14.25
- CNTA $27.00
- AVG Volume (30 Days)
- TALO 2.0M
- CNTA 730.3K
- Earning Date
- TALO 05-05-2025
- CNTA 05-14-2025
- Dividend Yield
- TALO N/A
- CNTA N/A
- EPS Growth
- TALO N/A
- CNTA N/A
- EPS
- TALO 0.14
- CNTA N/A
- Revenue
- TALO $2,055,748,000.00
- CNTA $15,000,000.00
- Revenue This Year
- TALO N/A
- CNTA N/A
- Revenue Next Year
- TALO N/A
- CNTA N/A
- P/E Ratio
- TALO $55.60
- CNTA N/A
- Revenue Growth
- TALO 31.54
- CNTA 118.88
- 52 Week Low
- TALO $6.23
- CNTA $7.90
- 52 Week High
- TALO $12.71
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- TALO 51.95
- CNTA 56.37
- Support Level
- TALO $7.68
- CNTA $12.11
- Resistance Level
- TALO $8.19
- CNTA $13.23
- Average True Range (ATR)
- TALO 0.25
- CNTA 0.73
- MACD
- TALO -0.00
- CNTA 0.12
- Stochastic Oscillator
- TALO 29.67
- CNTA 98.13
About TALO Talos Energy Inc.
Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. The revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.